Abstract
THE absence of a measurable pharmacological action of Staphylococcus enterotoxin in small laboratory animals limits investigation of the mode of action of this toxin. In view of published work in which drug interactions have been used to examine mechanisms of action1,2 we undertook an investigation of the toxicity of combined treatments of Staphylococcus enterotoxin and methyl-dopa in mice.
Similar content being viewed by others
Article PDF
References
Rossi, G. V., J. Pharmaceut. Sci., 53, 819 (1963).
Sugiyama, H., Bergdoll, M. S., and Dack, G. M., Proc. Soc. Exp. Biol. Med., 97, 900 (1958).
Reed, L. J., and Muench, H., Amer. J. Hygiene, 27, 493 (1938).
Hess, S., Connamacher, R. H., Ozaki, M., and Udenfriend, S., J. Pharmacol., and Exp, Therap., 134, 129 (1961).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
LAL, H., BLAIR, W., EHRLICH, R. et al. Combined Toxicity of Staphylococcal Enterotoxin and α-Methyl-3,4-dihydroxy-1-phenylalanine (Methyl-dopa). Nature 202, 1226 (1964). https://doi.org/10.1038/2021226a0
Issue Date:
DOI: https://doi.org/10.1038/2021226a0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.